Merck’s RSV jab shows efficacy in infants; Novo-Lilly weight loss rivalry intensifies as China okays tirzepatide
This was a week when the US President Joe Biden ended his reelection bid, after giving America the Inflation Reduction Act that...
Impressions : 1286
Court dismisses Astra’s lawsuit over IRA price talks; Ozempic shows benefits to kidney, heart in diabetics with CKD
This week’s Phispers brings updates on the Inflation Regulation Act (IRA) in the US. A federal district court judge rejec...
Impressions : 1146
Apotex blamed for FDA rejection of Biohaven`s new drug; Canada opposes Trump’s plan to import drugs
This week, Phispers brings you news about another setback to the Trump administration’s efforts at tackling high drug pri...
Impressions : 2915
EMA raises NDMA impurity concerns in diabetes drug made by Hetero; shareholder revolt rocks Bayer
This week, there is news on EMA telling companies using certain reagents to make diabetes drug — pioglitazone &mdash...
Impressions : 3987
China sees sharp rise in U.S. generic approvals; GSK opts out of Pfizer’s OTC business race
This week,
Phispers brings you news on Pfizer’s OTC auction. After Reckitt Benckiser, even GSK opted out of the race, le...
Impressions : 3737
FDA seeks changes in 180-day exclusivity for generics; Data-integrity concerns at Bayer`s German facility
This week, Phispers brings you news on the FY 2019 budget proposals in the US that seek to change the way generic drugs come to...
Impressions : 3765
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.